Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Altus Names Gemayel CEO; Milligan Becomes Gilead President

Executive Summary

Presidents & CEOs

You may also be interested in...



Conterno is new Lilly U.S. president

Lilly's U.S. president Deirdre Connelly resigned and will be succeeded by Enrique Conterno, currently senior VP for U.S. health care professional markets, the firm announces Jan. 30. Conterno perhaps beefed up his resume for the job after being appointed more responsibilities last year in overseeing efforts toward health professionals and neuroscience, diabetes and osteoporosis therapeutics when the company restructured to streamline R&D (1"The Pink Sheet," June 2, 2008, p. 25). The leadership shift is effective immediately

Conterno is new Lilly U.S. president

Lilly's U.S. president Deirdre Connelly resigned and will be succeeded by Enrique Conterno, currently senior VP for U.S. health care professional markets, the firm announces Jan. 30. Conterno perhaps beefed up his resume for the job after being appointed more responsibilities last year in overseeing efforts toward health professionals and neuroscience, diabetes and osteoporosis therapeutics when the company restructured to streamline R&D (1"The Pink Sheet," June 2, 2008, p. 25). The leadership shift is effective immediately

Lilly Leadership Falls To Lechleiter In ’08 As Taurel Resigns As CEO

The appointment of Lilly President and Chief Operating Officer John Lechleiter to CEO should be a smooth transition in early 2008 when longtime chief exec Sidney Taurel retires

UsernamePublicRestriction

Register

PS049685

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel